Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Sperm mitochondria dysfunction in response to testicular cancer

M. Qasemi, VP. Sur, O. Simonik, P. Postlerova, P. Skrobanek, T. Hradec, L. Boublikova, L. Zamecnik, T. Buchler, J. Neuzil, K. Komrskova

. 2024 ; 54 (4) : e14146. [pub] 20231208

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc24006607

Grantová podpora
CZ.1.05/1.1.00/02.0109 BIOCEV
RVO 86652036 Institute of Biotechnology of the Czech Academy of Sciences
NU20-03-00309 Ministry of Health of the Czech Republic

Testicular cancer is the most common form of cancer in young men of reproductive age and its incidence is increasing globally. With the currently successful treatment and 95% survival rate, there is a need for deeper understanding of testicular cancer-related infertility. Most patients with testicular cancer experience semen abnormalities prior to cancer therapy. However, the exact mechanism of the effect of testicular cancer on sperm anomalies is not known. Mitochondria are organelles that play a crucial role in both tumorigenesis and spermatogenesis and their malfunction may be an important factor resulting in sperm abnormalities in testicular cancer patients. Within the scope of this review, we will discuss current knowledge of testicular cancer-related alterations in the ATP production pathway, a possible pathophysiological switch from oxidative phosphorylation (OXPHOS) to glycolysis, as well as the role of oxidative stress promoting sperm dysfunction. In this regard, the review provides a summary of the impact of testicular cancer on sperm quality as a possible consequence of impaired mitochondrial function including the energy metabolic pathways that are known to be altered in the sperm of testicular cancer patients.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24006607
003      
CZ-PrNML
005      
20240729101004.0
007      
ta
008      
240412s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/eci.14146 $2 doi
035    __
$a (PubMed)38069497
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Qasemi, Maryam $u Laboratory of Reproductive Biology, Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic
245    10
$a Sperm mitochondria dysfunction in response to testicular cancer / $c M. Qasemi, VP. Sur, O. Simonik, P. Postlerova, P. Skrobanek, T. Hradec, L. Boublikova, L. Zamecnik, T. Buchler, J. Neuzil, K. Komrskova
520    9_
$a Testicular cancer is the most common form of cancer in young men of reproductive age and its incidence is increasing globally. With the currently successful treatment and 95% survival rate, there is a need for deeper understanding of testicular cancer-related infertility. Most patients with testicular cancer experience semen abnormalities prior to cancer therapy. However, the exact mechanism of the effect of testicular cancer on sperm anomalies is not known. Mitochondria are organelles that play a crucial role in both tumorigenesis and spermatogenesis and their malfunction may be an important factor resulting in sperm abnormalities in testicular cancer patients. Within the scope of this review, we will discuss current knowledge of testicular cancer-related alterations in the ATP production pathway, a possible pathophysiological switch from oxidative phosphorylation (OXPHOS) to glycolysis, as well as the role of oxidative stress promoting sperm dysfunction. In this regard, the review provides a summary of the impact of testicular cancer on sperm quality as a possible consequence of impaired mitochondrial function including the energy metabolic pathways that are known to be altered in the sperm of testicular cancer patients.
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    12
$a testikulární nádory $x metabolismus $7 D013736
650    _2
$a sperma $x metabolismus $7 D012661
650    _2
$a analýza spermatu $7 D055101
650    _2
$a spermie $7 D013094
650    12
$a mitochondriální nemoci $x metabolismus $7 D028361
650    12
$a germinální a embryonální nádory $7 D009373
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Sur, Vishma Pratap $u Laboratory of Reproductive Biology, Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic
700    1_
$a Simonik, Ondrej $u Laboratory of Reproductive Biology, Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic
700    1_
$a Postlerova, Pavla $u Laboratory of Reproductive Biology, Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic $u Department of Veterinary Sciences, Faculty of Agrobiology, Food and Natural Resources, Czech University of Life Sciences Prague, Praha, Czech Republic
700    1_
$a Skrobanek, Pavel $u Department of Oncology, First Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic
700    1_
$a Hradec, Tomas $u Department of Urology, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Boublikova, Ludmila $u Department of Oncology, First Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic
700    1_
$a Zamecnik, Libor $u Department of Urology, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Buchler, Tomas $u Department of Oncology, First Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic $u Department of Oncology, Second Faculty of Medicine and Motol University Hospital, Prague, Czech Republic
700    1_
$a Neuzil, Jiri $u Laboratory of Molecular Therapy, Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic $u School of Pharmacy and Medical Science, Griffith University, Southport, Queensland, Australia
700    1_
$a Komrsková, Kateřina, $d 1974- $u Laboratory of Reproductive Biology, Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic $u Department of Zoology, Faculty of Science, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000268372148 $7 jx20100128015
773    0_
$w MED00009632 $t European journal of clinical investigation $x 1365-2362 $g Roč. 54, č. 4 (2024), s. e14146
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38069497 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240412 $b ABA008
991    __
$a 20240729101003 $b ABA008
999    __
$a ok $b bmc $g 2080922 $s 1216374
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 54 $c 4 $d e14146 $e 20231208 $i 1365-2362 $m European journal of clinical investigation $n Eur J Clin Invest $x MED00009632
GRA    __
$a CZ.1.05/1.1.00/02.0109 $p BIOCEV
GRA    __
$a RVO 86652036 $p Institute of Biotechnology of the Czech Academy of Sciences
GRA    __
$a NU20-03-00309 $p Ministry of Health of the Czech Republic
LZP    __
$a Pubmed-20240412

Najít záznam

Citační ukazatele

Možnosti archivace